These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Author: Henneberg-Quester KB, Luboldt W, Schaefer UW, Beelen DW, Quabeck K.
    Journal: Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830.
    Abstract:
    About 2 or 3 weeks after transplantation, even ABO-Incompatible bone marrow shows a successful graft. Haemopoiesis is not always free of problems. Suppression of erythropoiesis is caused by persistently incompatible agglutinins. Patient's well-being is limited by longer periods of low levels of haemoglobin concentration. Long-lasting need for transfusions is related to the well-known risk of infections. A procedure to eliminate the residual titers of alloantibodies should be discussed in time with the staff of the transfusion department.
    [Abstract] [Full Text] [Related] [New Search]